Copyright
©The Author(s) 2005.
World J Gastroenterol. Jul 21, 2005; 11(27): 4210-4214
Published online Jul 21, 2005. doi: 10.3748/wjg.v11.i27.4210
Published online Jul 21, 2005. doi: 10.3748/wjg.v11.i27.4210
150 mg | 300 mg | P | ||
Age (yr) | 44 ± 9 | 45 ± 12 | 0.8141 | |
Sex | Male | 7 | 5 | 0.734 |
Female | 6 | 8 | ||
Weight | 64 ± 11 | 61 ± 12 | 0.4281 | |
Duration of reflux disease | < 6 mo | 5 | 2 | 0.412 |
6 -2 yr | 6 | 8 | ||
> 2 yr | 2 | 3 | ||
Pre-medication | Yes | 2 | 1 | 0.828 |
No | 11 | 12 | ||
Endoscopy | 0 | 5 | 7 | 0.717 |
(Savary-Miller grade) | ||||
I | 7 | 5 | ||
II | 1 | 1 | ||
Drinking | Yes | 2 | 3 | 0.884 |
No | 11 | 10 | ||
Smoking | Yes | 3 | 3 | 1 |
No | 10 | 10 |
- Citation: Kim YS, Kim TH, Choi CS, Shon YW, Kim SW, Seo GS, Nah YH, Choi MG, Choi SC. Effect of itopride, a new prokinetic, in patients with mild GERD: A pilot study. World J Gastroenterol 2005; 11(27): 4210-4214
- URL: https://www.wjgnet.com/1007-9327/full/v11/i27/4210.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i27.4210